Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | ASCO lung cancer highlights

Roy Herbst, MD, PhD, FACP, FASCO, of Yale University, New Haven, CT, discusses some of the key lung cancer updates presented at ASCO 2019, specifically mentioning treatments targeting KRAS and the drug ramucirumab. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.